Noteworthy, no significant changes in TGF-βRI expression, in SMAD3 localization nor in vascularization, were observed in chemosensitive HCT116 xenograft tumor sections (Supplementary Figure S1), suggesting that the observed molecular events are selective for chemoresistant tumors. The gene discussed is SMAD3; the disease is neoplasm.